Office of Drug Czar Representative to Speak at NABP Symposium on Medical Marijuana

Thursday, October 22, 2009 General News
Email Print This Page Comment bookmark
Font : A-A+

MOUNT PROSPECT, Ill., Oct. 21 The National Association of Boards of Pharmacy(R) (NABP(R)) welcomes Office of National Drug Control Policy drug policy expert Kevin Sebat to speak at its 2009 Symposium. On December 3, 2009, Sebat will discuss the current federal laws regarding marijuana as well as the recent policy shift regarding prosecution of medical marijuana cases in states that have legalized the practice. Symposium participants will learn how marijuana became a Schedule I controlled substance and the future of this status in light of recent policy shifts.

The October 19 Department of Justice memo calls for a focus on prosecution of significant traffickers of illegal drugs and the disruption of illegal drug manufacturing and trafficking networks, rather than pursuing individuals whose actions comply with existing state and local laws providing for the medical use of marijuana. Currently, 14 states allow for the sale and use of medical marijuana including Alaska, California, Colorado, Hawaii, Maine, Maryland, Michigan, Montana, Nevada, New Mexico, Oregon, Rhode Island, Vermont, and Washington. (To view the Department of Justice memo visit

This action represents a shift in drug prosecution policy to ensure the effective use of prosecutor and investigator resources; however, the Department of Justice memo states that it does not change the Controlled Substances Act which categorizes marijuana as a Schedule I controlled substance. Some advocates of medical marijuana see the move as a harbinger of the federal government recognizing the medicinal properties of marijuana.

During the NABP Symposium, board of pharmacy members and other pharmacy stakeholders will spend a full day discussing the science behind medical marijuana, state regulations addressing its use, and the social and financial impact of the substance. Also discussed will be Canada's experience with national legalization of medical marijuana. Additionally, a panel of experts on both the pro and con sides will debate the issue of legalization.

The NABP Symposium will be held December 3-4, 2009, at the J.W. Marriott Starr Pass Hotel in Tucson, AZ. Educational sessions held on December 4 will cover public-private partnership opportunities for boards of pharmacy.

For a full description of the continuing pharmacy education sessions or to register for the 2009 Symposium, visit the Meetings section of the NABP Web site at

NABP is the independent, international, and impartial Association that assists its member boards and jurisdictions in developing, implementing, and enforcing uniform standards for the purpose of protecting the public health.

NABP and the NABP Foundation is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. ACPE Provider Number: 205. Participants may earn ACPE-approved continuing pharmacy education credit from NABP. Participants in continuing pharmacy education programs will receive credit by completing a "Statement of Continuing Pharmacy Education Participation" and submitting it to the NABP office. A validated Statement of Credit will be sent as proof of participation within approximately six weeks. Full attendance and completion of a program evaluation form for each session are required to receive continuing pharmacy education credit and a Statement of Credit.

SOURCE National Association of Boards of Pharmacy

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store